Nuance strikes deal to acquire Dictaphone for $357 million

Article

Voice recognition software developer Nuance has cut a deal to acquire Dictaphone. Nuance executives say they expect the all-cash $357 million agreement to accelerate the adoption of voice recognition as a replacement for manual transcription.

Voice recognition software developer Nuance has cut a deal to acquire Dictaphone. Nuance executives say they expect the all-cash $357 million agreement to accelerate the adoption of voice recognition as a replacement for manual transcription.

"It is our goal by the end of this decade to replace most manual transcription in healthcare with speech-enabled automated solutions, giving care providers and medical transcription services the ability to reduce manual transcription costs by over $5 billion a year," said Paul Ricci, chairman and CEO of Nuance.

U.S. medical providers spend about $10 billion annually to transcribe spoken reports, according to Ricci.

The deal to merge Dictaphone and Nuance is expected to close March 31, pending regulatory approvals and due diligence. If it does, Dictaphone will operate as a wholly owned subsidiary of Nuance.

Editor's Note: What the merger will mean for Nuance, Dictaphone, and the medical community at large will be featured in the Feb. 20 issue of SCAN.

Recent Videos
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
Related Content
© 2025 MJH Life Sciences

All rights reserved.